Literature DB >> 7624148

The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth.

N S Pellegata1, J F Cajot, E J Stanbridge.   

Abstract

To investigate the relevance of the C-terminal domains of the human p53 tumor suppressor gene to its growth suppressive and transcriptional regulatory properties deletion mutants were generated which eliminated 30 (p53 delta 363), 60 (p53 delta 333) and 87 (p53 delta 306) amino acids from the C-terminus of the p53 protein. p53 delta 363 has lost the highly basic tail of the protein (residues 360-386). p53 delta 333 and p53 delta 306 lack the oligomerization domain (residues 320-360); p53 delta 306 has also lost the major nuclear localization signal of p53 (NLSI, residues 316-325). These mutants were assayed for transactivation from two p53 consensus binding sites and for transcriptional repression of two promoter systems in Calu6 lung cancer cells (p53 null). Moreover, their ability to inhibit cell growth in tumor cell lines with a defined p53 status was analysed. Deletion of the oligomerization domain correlated with significant loss of: (a) transactivation from a genomic sequence; (b) transcriptional repression; (c) the ability to inhibit colony formation. An intact NLSI was not a prerequisite for transactivation. p53 delta 363 behaved similarly to wt p53 in all the assays. We established an inducible expression system for p53 delta 363 in a human fibrosarcoma cell line known to be growth-suppressed by wt p53. The induction of p53 delta 363 expression also inhibited cell proliferation albeit to a lesser extent than wt p53. However, p53 delta 363 could upregulate WAF1/CIP1, GADD45 and MDM2 genes. Thus, the basis tail of p53 appears not to be required for the biological functions of the protein assayed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7624148

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

Authors:  J S Steffan; A Kazantsev; O Spasic-Boskovic; M Greenwald; Y Z Zhu; H Gohler; E E Wanker; G P Bates; D E Housman; L M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes.

Authors:  Pierre-Jacques Hamard; Dana J Lukin; James J Manfredi
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

3.  Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.

Authors:  A L Okorokov; F Ponchel; J Milner
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

4.  Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.

Authors:  Heejei Yoon; Sandya Liyanarachchi; Fred A Wright; Ramana Davuluri; Janet C Lockman; Albert de la Chapelle; Natalia S Pellegata
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

5.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Heide Siggelkow; Elenore Samson; Karin Bink; Heinz Höfler; Falko Fend; Jochen Graw; Michael J Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

6.  The absence of Msh2 alters abelson virus pre-B-cell transformation by influencing p53 mutation.

Authors:  J Jenab-Wolcott; D Rodriguez-Correa; A H Reitmair; T Mak; N Rosenberg
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

7.  DNA damage and p53-mediated cell cycle arrest: a reevaluation.

Authors:  N S Pellegata; R J Antoniono; J L Redpath; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain.

Authors:  M W Frazier; X He; J Wang; Z Gu; J L Cleveland; G P Zambetti
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.